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Abstract  
Introduction: Despite roll-out of cost-effective point-of-care tests, less than half antenatal attendees in rural western Zambia are screened for 
syphilis. This study formulated a clinical, risk-based assessment criteria and evaluated its usefulness as a non-biomedical alternative for identifying 
high-risk prenatal cases. Methods: We conducted a cross-sectional survey of antenatal clinic attendees in Kaoma, Luampa and Nkeyema districts 
to collect data on exposure to nine pre-selected syphilis risk factors. These factors were classified into major and minor factors based on their 
observed pre-study association strengths to maternal syphilis. Clinical disease was defined as exposure to either two major factors, one major with 
two minor factors or three minor factors. Sensitivity, specificity and predictive values of the clinical protocol were then calculated in comparison to 
rapid plasmin reagin results. Results: The observed syphilis prevalence was 9.3% (95% CI: 7.4 - 11.6%) and the overall sensitivity of the study 
criteria was 62.3% with positive predictive value of 72.9%. Sensitivities of individual case-defining categories were even lower; from 17.4% to 
33.3%. Results confirmed that abortion history, still birth, multiple sexual partners, previous maternal syphilis infection, partner history of sexually 
transmitted infection and maternal co-morbid conditions of HIV and genital ulcer disease were significantly associated to maternal syphilis in study 
population as well. Conclusion: The criteria was not as effective as biomedical tests in identifying maternal syphilis. However, it could be a useful 
adjunct/alternative in antenatal clinics when biomedical tests are either inadequate or unavailable. 
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An estimated 11 million people are infected with syphilis globally 
every year; of these 1.5 million are pregnant women [1]. Maternal 
syphilis can lead to adverse pregnancy outcomes (APO) in 53.4 - 
81.8% cases [2] such as spontaneous abortions, intra-uterine 
growth retardation, still births, premature deliveries, low-birth 
weight, perinatal deaths and congenital disease among new-born 
babies [3, 4]. To contribute towards control of maternal syphilis and 
its APOs, the World Health Organization (WHO) recommends 
antenatal screening of all pregnant women [5]. Many countries in 
sub-Saharan Africa (SSA) including Zambia, which have some of the 
highest levels of infection, introduced the WHO syphilis-screening 
recommendations into national antenatal care (ANC) guidelines 
[6, 7]. However, most of these SSA countries have challenges 
ensuring 90% antenatal access to syphilis screening services. In 
2010, of the 27 countries in SSA that submitted a report, only 
Namibia achieved this target. The median coverage for syphilis 
screening in the reporting countries was 59% [8]. Zambia, on 
average, screens 44% pregnant women every year and the rural 
areas of the western province are among the worst affected. As a 
result of this, an estimated 241 prenatal syphilis infections are 
missed annually in three districts (Kaoma, Luampa and Nkeyema) of 
this province alone [9, 10]. To ensure universal access to antenatal 
syphilis testing, a number of studies have recommended the use of 
point-of-care (POC) biomedical tests [1,11, 12]. To this effect, in 
2012, Zambia introduced more cost effective and logistically simpler 
rapid syphilis tests (RST) [3, 6] to the existing antenatal screening 
guidelines that originally provided only for use of rapid plasmin 
reagin tests (RPR) [13]. Despite this, there has been minimal 
improvement in screening levels indicating existence of possible 
performance gaps related to health systems, political support and 
resources allocation for the programme [14,15]. Understandably, to 
address existing performance gaps, the main focus for research in 
this area has been developing more cost-effective, biomedical 
means of screening for syphilis as infections can be asymptomatic. 
We argue that a need exists to find alternative methods for use in 
identifying women at high risk of infection when biomedical test are 
unavailable. Currently, ANC providers receive no guidance from the 
WHO and national guidelines on alternative measures to control 
maternal syphilis when biomedical tests are unavailable for any 
reason. A few studies, whilst in the process of conducting cost-
effectiveness studies of biomedical testing, explored alternative 
control-strategies such as empirical treatment of all pregnant 
women [16-18] and presumptive syphilis diagnosis based on 
presence of genital ulcer disease (GUD) [11]. Results have shown 
that these alternative methods could be relatively cheaper than 
conventional methods, however, concerns of unnecessary over-
treatment of antenatal attendees have discouraged their 
recommendation for general use [18]. Arising from this, we sought 
to explore the possibility of using a clinical protocol, based known 
risk factors of maternal syphilis, as an alternative syphilis 
identification method. The rationale was based on availability of 
documented evidence of risk factors associated with maternal 
syphilis which could be categorized in a clinical protocol. These risk 
factors included; a maternal history of previous infection with 
syphilis, history of abortion [19], history of multiple sexual partners 
[20], early maternal age at sexual debut [21], obstetric history of 
still birth delivery [22, 23], HIV co-infection [24], presence of genital 
ulcer disease [11, 25] and a history of sexually transmitted infection 
in the partner [26]. We then evaluated the sensitivity, specificity 
and predictive values of the designed protocol. We further, sought 
to review how these findings would influence performance gaps in 
antenatal syphilis screening guideline implementation in three 





Design and sampling procedures 
  
We conducted a cross-sectional study in Kaoma, Luampa and 
Nkeyema districts, western province, Zambia from April to June 
2015. This is the most populated region of the province with 
122,092 inhabitants, majority of whom are women of child bearing 
age with annual expected pregnancies of 10,531 and average first 
antenatal attendances of 9,989. The region has 34 public health 
facilities offering ANC services. The primary sample was selected 
using one-stage cluster design which guided the initial selection of 
eight (8) health facility clusters using systematic random technique 
from a list public health facilities in the study region. Respondents 
were then recruited by selecting all consenting pregnant women 
attending antenatal clinic in the sampled clusters during the study 
period. The secondary sample included 10 health facility staff from 
these sites as well as 3 district health programme managers 
selected purposefully. We collected data on past exposure to risk 
factors of maternal syphilis from primary respondents. The RPR 
blood test performed on consenting respondents was gold standard 
syphilis test. We also performed a record review of; antenatal 
records, antenatal screening policy guidelines, district health 
systems in relation staff capacities and logistics management and 




A structured interviewer-administered questionnaire was used for 
data collection. The tool was translated into Lozi, the main local 
language in the study region, and pre-tested for consistency. The 
regular ANC providers were recruited as research assistants and the 
questionnaire was administered in normal antenatal clinic setting to 





Blood screening for syphilis was done after administration of the 
questionnaire to minimise bias. The study provided test kits to 
facilities when unavailable. The test was conducted under the usual 
antenatal conditions using the IMMUTREP RPR, a non-treponemal 
flocculation syphilis test. Approximately 50µl venous whole blood 
sample from each consenting respondent was mixed with one free-
falling drop of test antigen on a test card. The mixing was aided by 
rotating the test cards for 8 minutes after which the results were 
read. 
  
Proposed clinical assessment criteria 
  
Risk factors were categorized into major factors which included: a 
maternal history of previous infection with syphilis, presence of 
genital ulcer disease, history of multiple sexual partners, HIV co-
infection and minor factors; history of abortion, early maternal age 
at sexual debut, obstetric history of still birth delivery and neonatal 
death, as well as a history of sexually transmitted infection in the 
partner. This classification was based on observed strength of 
association or frequency of linkage of these risk factors to maternal 
syphilis infections with cut-off set at odds ratio of 5 and frequency 
of 10%. Clinical disease was then defined as either the presence of 
two (2) major risk factors or one (1) major and two (2) minor risk 
factors or three (3) minor risk factors. 
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Data analysis 
  
The data from the questionnaires was coded, checked and cleaned 
before entry into a Microsoft excel sheet and imported into Stata 
version 13 for analysis. Data on risk factor identification and 
laboratory results were assigned numbers either 1 or 2 depending 
on presence or absence of a risk factor or disease. These were then 
entered in Microsoft excel and imported into Stata version 13. 
Proportions were used to estimate prevalence of maternal syphilis. 
Since data variables of risk factors was dichotomous, univariate and 
multivariate analysis for binary outcomes was done to find the 
relationship to maternal syphilis with odds ratio and chi-square as 
measures of association. Multiple logistic regression was done to 
test for significance set at 95% confidence level with p value < 
0.05. Using RPR as confirmatory test, the sensitivity, specificity and 
predictive values of the proposed criteria were calculated to 
measure its usefulness in identifying maternal infections. The 
accuracy of the assessment criteria was ascertained by calculating 
the area under the receiver operating curve (ROC) which compared 
ability of a test to differentiate between those with disease and 
those without. A ROC of greater than 0.80 was deemed to have 
good accuracy, while 0.70 to 0.80 was fair and less than 0.70 was 
deemed to be poor. We used content analysis method to summarize 
qualitative data from desk review and health personnel unstructured 
interviews. This was then reported by use of narratives which in 




Ethics approval was obtained from Excellence in Research Ethics 
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A total 740 respondents who gave complete responses were 
recruited in the study. The majority; 360 (48.6%) were aged 
between 20 and 30 years with a mean age of 26 ± 0.5 years. The 
results also showed that a greater proportion of the respondents; 
445 (60.1%) were married, had more than one pregnancy; 572 
(77.3%) and were unlikely to have gone beyond primary level of 
school education; 497 (67.2%). 
  
Syphilis sero-positivity in study population 
  
The syphilis sero-positivity using RPR tests was observed to be 
9.3% (95% CI: 7.4 -11.6%) among study participants. Of the 
women testing positive, 61 (87.1%) were multigravidas as opposed 
to 9 (12.9%) who were in their first pregnancy. 
  
Correlates between risk-factors and maternal syphilis 
infections among respondents 
  
A univariate comparison of risk factors to maternal syphilis showed 
that cases were more likely to have a history of abortion, a history 
of still birth delivery, to have previously lost a baby in the first 
month of birth, to have previous infection with syphilis, to have a 
sexual partner with a sexually transmitted infection, to have had 
multiple sexual partners in past (two) 2 years, to have genital ulcer 
disease and be HIV co-infected. However, the association between 
maternal syphilis infection and early sexual debut (before the age of 
16 years) at this stage was found not to be statistically significant as 
the chi-square test for this association was found to have a P-value 
greater than 0.05 (Table 1). We then conducted a multivariate 
logistics analysis excluding early age at sexual debut. After 
controlling for all variables we found that co-morbid conditions of 
HIV and genital ulcer disease and exposure histories of still birth 
delivery and previous infection with syphilis were strongly 
associated with syphilis sero-positivity (OR>5). Other risk factors 
such as history of abortion, having more than one sexual partners 
and sexually transmitted infection in a sexual partner were also 
significantly associated with gestational syphilis infections (OR:3 to 
5). At this stage, we also found that a history of losing a neonate 
through death was not significantly associated to maternal syphilis 
(OR 2.3, p value> 0.05) (Table 2). Therefore only seven (7) of the 
nine (9) preselected factors in the end were found to be significantly 
associated with maternal syphilis. 
  
Sensitivity, specificity and predictive value of proposed risk 
assessment criteria 
  
The proposed assessment criteria identified 59 (8%) of the 
respondents with presumptive clinical disease. Of these, 43 were 
true positive (TP) cases of syphilis. The criteria also identified 655 
women as true negatives (TN). However, 26 (37.7%) women with 
disease were missed and 27.1% were incorrectly classified as 
diseased when they were syphilis sero-negative. The overall 
sensitivity of the assessment criteria was 62.3% with a positive 
predictive value (PPV) of 72.9% and its specificity was 97.6% with a 
negative predictive value (NPV) of 96.2%. The area under the 
receiver operating curve (ROC) at 0.780 corresponded to a fair 
accuracy result (Table 3). The individual case definition categories 
showed lower sensitivities than their combined effect. Presence of 
two major risk factors was more sensitive at 33.3% sensitivity, 
followed by the category with one major and two minor factors and 
the least was the category with three minor factors. The areas 
under the ROC for the individual case categories were all lower than 
0.7 showing their reduced accuracy. 
  
Observed Gaps in the antenatal syphilis screening 
guidelines 
  
ANC guidelines require first visit syphilis screening for pregnant 
women, however biomedical tests availability is a challenge due to; 
under-supply ( in all eight facilities), irregular submission of 
commodity consumption data for quantification of supply (two 
facilities) and inadequate resource allocation at district level to 
supplement supply; Although syndromic STI management is 
practiced in STI clinics, this is not practiced in antenatal clinic and 
antenatal attendees are left untreated in absence of biomedical 
tests; All ANC frontline staff were oriented on simple technique of 
using RST however they were not fully aware of revision in syphilis 





This study confirmed that most of the pre-selected socio-
demographic, behavioural and medical risk factors were significantly 
associated with maternal syphilis infection even in the study 
population validating their inclusion in the clinical assessment 
protocol. Respondents with syphilis were not only more likely to 
have co-morbid conditions like HIV and genital ulcer disease but 
also reported a history of multiple sexual partners, previous 
abortion, previous still birth delivery, previous syphilis infection and 
having a sexual partner with a sexually transmitted infection. The 
overall sensitivity of the protocol compared well to off-site field 
validation tests for point of care (POC) treponemal tests conducted 
in a syphilis clinic in Manaus, Brazil. In this study, off-site POC tests 
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were reported to have sensitivities in the range of 45.8 to 66.7% 
[27]. The sensitivity of this study's assessment criteria however, 
with its inherent limitations was inferior to the widely recommended 
on-site rapid syphilis screening tests such as treponemal-based 
immuno-chromatographic strips (ICS). The latter have been 
reported to have field sensitivities ranging from 85 to 95% [28,29]. 
The possible sources of bias included information bias as it is 
unclear whether there were any risk factors relevant to the local 
study population omitted from the assessment criteria. Further, 
evaluation of clinical disease was essentially based on self-reported 
exposure to risk factors. It is likely therefore that the results may be 
affected by the participants' ability and willingness to recall and 
disclose exposure to certain risk behaviours. Generally, the clinical 
protocol performed reasonably well in predicting maternal syphilis 
infections even though the proportion of clinically presumed 
infections (8%) was lower than the actual sero-positive cases 
(9.3%). We considered the possibility that the observed protocol's 
performance might be due to sample-size related over-estimation of 
sero-prevalence which differed considerably from routine data in the 
study area. The 2007 Zambia Demographic Health Survey (ZDHS) 
estimated 4% prevalence levels among women of reproductive age 
group [30] and an observational study by Makasa et al showed 
declining national syphilis prevalence trends in concurrence to 
declines in HIV prevalence in Zambia [31]. 
 
However, this study's observed maternal syphilis sero-prevalence 
compares well to estimates from other studies in the country which 
generated information from antenatal clinics. In 2014 a study to 
evaluate rapid Dual HIV and syphilis tests, at the University 
Teaching Hospital in Lusaka, showed syphilis prevalence of 9.5% 
among women attending antenatal clinic [32]. This was similar to 
what was observed by Makasa et al, when they found high sero-
prevalence of 10.8% in rural sites of Western province using 
antenatal sentinel surveillance data [31]. It is unclear although 
reasonable to assume that the disease-prediction performance of 
the clinical protocol would be affected by prevalence level of the 
disease. Therefore, additional and broader studies need to be 
performed to evaluate variability of the criteria's results at different 
syphilis point prevalence levels. The difficulty in predicting syphilis 
infections clinically with symptoms or risk factors is one of the main 
reasons WHO guided national policies recommend antenatal testing 
for all pregnant women using biomedical tests. However, despite 
having a policy in place, there are still challenges in ensuring that all 
ANC attendees access syphilis screening services. Some of these 
challenges arise from weaknesses in health systems such as; 
ineffective laboratory commodity supply and reporting systems, 
partial roll-out of the more cost-effective and easier to use RST and 
inadequate dissemination of revised screening guidelines. The 
overriding challenge affecting antenatal syphilis screening is the 
limitations in resources allocation to ensure availability of biomedical 
tests. The current level of commodity supply of biomedical syphilis 
test in the study area does not reflect political will to adhere to 
recommended policy of screening "all women attending antenatal 
clinic". Maintaining political will during implementation in Zambia is 
still a challenge despite recommendations which were accepted by 
the Ministry of Health to introduce point-of-care RST tests in 
national syphilis control guidelines [3]. This political will may 
diminish further as data show declining trends of syphilis prevalence 
[31]. There seems to be limited available alternatives to this 
problem. Some researchers have therefore recommended 
development of a dual test that would incorporate the much more 
politically acceptable HIV antenatal test [29] or epidemiological 
treatment for all pregnant women. This study's proposed clinical 
assessment protocol may be useful in identifying high risk infections 
for treatment. It could therefore be used for selective syphilis 
screening in declining disease-prevalence situations to limit costs of 
biomedical testing. It could also be used as an alternative screening 
tool in situations when biomedical tests are unavailable and in this 
situation it carries the advantage over epidemiological treatment in 






This study was able to illustrate that a clinical assessment protocol 
that is based on known socio-demographic, behavioral and medical 
risk factors of maternal syphilis can be used to identify women at 
high risk of infection. Despite its diagnostic limitations the protocol 
offers an alternative screening method, lacking in the national 
syphilis control guidelines, that could be used by frontline care 
providers. Even though Biomedical syphilis tests remain the most 
cost-effective means of identifying antenatal syphilis infections, 
there are some challenges related to health delivery systems in 
Zambia that have affected regular commodity availability. However, 
the proposed clinical protocol could offer an acceptable means of 
either identifying some cases in absence of biomedical tests or 
prioritizing those to be screened especially in resource limited 
settings. 
 
What is known about this topic 
 
• Biomedical tests such as RPR and RST are known to be 
cost-effective methods of screening for syphilis and are 
recommended in most National Antenatal Care Guidelines 
for control of maternal syphilis and its adverse outcomes; 
• The national antenatal guidelines reviewed offer care 
providers no alternatives to biomedical testing for 
identifying high risk cases in limited supply settings; 
• There are several socio-demographic, behavioural and 
medical risk factors of maternal syphilis which have not 
being categorized into a protocol to predict infections. 
 
What this study adds 
 
• The study proposed for the first time, a clinical 
assessment protocol based on known risk factors of 
maternal syphilis for use in either guiding presumptive 
treatment of women at high risk of infection or as adjunct 
to biomedical testing in situations where screening tests 
are either unavailable or in limited supply respectively; 
• The study tested the sensitivity of the clinical protocol 
which was not high enough to replace biomedical tests 
but sufficiently useful to be recommended for inclusion in 
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Table 1: Univariate analysis: association between risk factors and 
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OR (95% CI) P value 
Abortion history         
No 39 (66.1%) 478 (93.4%) 1.00   
Yes 20(33.9%) 34 (6.6%) 7.21 (3.80-13.69) <0.001 
Still birth history         
No 44 (77.2%) 493 (96.3%) 1.00   
Yes 13 (22.8%) 19 (3.7%) 7.67 (3.55-16.56) <0.001 
Neonatal death history         
No 50 (86.2%) 495 (95.6%) 1.00   
Yes 8 (13.8%) 23 (4.4%) 3.44 (1.46-8.10) 0.003 
Previous Syphilis infection         
No 49 (71.0%) 641 (97.7%) 1.00   
Yes 20 (29.0%) 15 (2.3%) 17.44 (8.41-36.18) <0.001 
Genital ulcer disease         
No 52 (76.5%) 652 (97.9%) 1.00   
Yes 16 (23.5%) 14 (2.1%) 14.3 (6.62-30.97) <0.001 
Early sexual debut <16yrs         
No 36 (52.2%) 424 (63.2%) 1.00   
Yes 33 (47.8%) 247 (36.8%) 1.57 (0.96-2.56) 0.072 
Multiple sexual partners         
No 48 (69.6%) 573 (86.75%) 1.00   
Yes 21 (30.4%) 96 (14.4%) 2.6 (1.50-4.56) <0.001 
Partner STI infection         
No 37 (64.9%) 503 (94.2%) 1.00   
Yes 20 (35.1%) 31 (5.8%) 2.6 (1.50-4.56) <0.001 
HIV infection         
No 50 (72.5%) 648 (96.6%) 1.00   
Yes 19 (27.5%) 23 (3.4%) 10.7 (5.47-20.07) <0.001 
OR=Odds ratio, CI=Confidence Interval 
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OR (95% CI) P value 
Abortion history         
No 39 (66.1%) 478 (93.4%) 1.00   
Yes 20 (33.9%) 34 (6.6%) 4.5 (1.82 – 11.21) 0.001 
Still birth history         
No 44 (77.2%) 493 (96.3%) 1.00   
Yes 13 (22.8%) 19 (3.7%) 6.4 (1.92 – 21.05) 0.002 
Neonatal death history         
No 50 (86.2%) 495 (95.6%) 1.00   
Yes 8 (13.8%) 23 (4.4%) 2.3 (0.59 – 9.28) 0.228 
Previous Syphilis infection         
No 49 (71.0%) 641 (97.7%) 1.00   
Yes 20 (29.0%) 15 (2.3%) 6.1 (2.07 – 17.81) 0.001 
Genital ulcer disease         
No 52 (76.5%) 652 (97.9%) 1.00   
Yes 16 (23.5%) 14 (2.1%) 6.4 (1.68 – 24.74) 0.007 
Multiple sexual partners         
No 48 (69.6%) 573 (86.7%) 1.00   
Yes 21 (30.4%) 96 (14.4%) 4.0 (1.56 – 10.04) 0.004 
Partner STI infection         
No 37 (64.9%) 503 (94.2%) 1.00   
Yes 20 (35.1%) 31 (5.8%) 3.3 (1.32 – 8.26) 0.011 
HIV infection         
No 50 (72.5%) 648 (96.6%) 1.00   
Yes 19 (27.5%) 23 (3.4%) 8.4 (3.26 – 21.49) 0.001 
OR=Odds ratio, CI=Confidence Interval 
Non-exposure response to risk factors reference   






Table 3: sensitivity, specificity and predictive value of proposed risk assessment criteria 
Screening 
criteria 




TP:43  FP:16 





33.3% 98.9% 76.7% 93.5% 0.662 
One major 
and two minor 
risk factors 
TP:20 FP:6 





17.4% 99.4% 75.0% 92.1% 0.584 
TP = True positives. FP = False positives. TN = True negatives. FN = False negatives 
PPV = Positive predictive value. NPV = Negative predictive value 
  
 
